TXG - CIK 0001770787
The table below shows 10x Genomics, Inc.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | - | - | - | - | - | - |
| Short-term investments | - | - | - | - | - | - |
| Receivables | $39.03M | $43.78M | $49.98M | $52.55M | $83.53M | $91.18M |
| Inventory | $53.49M | $61.96M | $68.97M | $74.71M | $94.05M | $88.27M |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $669.73M |
| $659.83M |
| $655.66M |
| $579.73M |
| $593.89M |
| $579.15M |
| Property, plant & equipment | $220.59M | $232.53M | $239.71M | $246.09M | $258.76M | $263.29M |
| Goodwill | $4.51M | $4.51M | $4.51M | $4.51M | $4.51M | $4.51M |
| Total assets | $1.02B | $1.03B | $979.97M | $903.39M | $937.79M | $929.67M |
| Accounts payable | $17.43M | $18.07M | $15.94M | $10.07M | $26.21M | $21.25M |
| Total current liabilities | $113.60M | $147.32M | $112.22M | $107.90M | $121.23M | $111.02M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $201.44M | $242.24M | $206.69M | $196.50M | $214.99M | $205.61M |
| Retained earnings | -$1.52B | -$1.49B | -$1.47B | -$1.50B | -$1.42B | -$1.38B |
| Total equity | $814.32M | $785.12M | $773.28M | $706.89M | $722.80M | $724.06M |